/Lists

Biotech Investors & VC Firms in United States

1619 firms in this list, with a median first check of $500K. 402 of them lead rounds. Generated from verified public data and updated continuously.

Unorthodox Ventures
AustinSeed–Growth$1M – $5M
16 people
Delos Capital
CambridgePre-Seed–Growth
15 people
Forward Deployed VC
Pre-Seed–Series A
3 people
MassVentures
WalthamPre-Seed–Seed$250K – $500K
9 people
Taihill Venture
BostonPre-Seed–Seed
11 people
Altaris Capital Partners
New York
22 people
Qiming Venture Partners USA
CambridgeSeed–Series B
19 people
Plum Alley Investments
New YorkSeed–Series A$500K – $1.5M
15 people
Alix Ventures
San FranciscoSeed–Series A$100K – $500K
18 people
Asset Management Company
Menlo ParkSeed–Series A$500K – $2M
6 people
One Planet Capital
CambridgePre-Seed–Seed$25K – $500K
6 people
WMU Biosciences Research & Commercialization Center
KalamazooPre-Seed–Series A$100K – $250K
12 people
Gore Range Capital
New YorkSeries A–Late Stage$500K – $5M
17 people
FAST — by GETTYLAB
San FranciscoPre-Seed–Seed$100K
1 person
Omega Funds
BostonSeed–Late Stage
19 people
Rhapsody Venture Partners
CambridgePre-Seed–Seed$500K – $2M
10 people
Westlake Village BioPartners
Los AngelesPre-Seed–Series A$100K – $5M
13 people
Deep Future
Seattle
3 people
BIOSPRING PARTNERS
New YorkGrowth
23 people
Necessary Ventures
San FranciscoPre-Seed–Seed$1M – $2M
11 people
Shanda Group
Redwood CityPre-Seed–Seed
23 people
Starlight Ventures
MiamiPre-Seed–Series B$100K – $3M
7 people
Next Ventures
AustinSeed–Series A$500K – $3M
9 people
Behind Genius Ventures
San DiegoPre-Seed–Series A$250K – $500K
5 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.